The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa
Abstract
:1. Introduction
2. HPV Infection Increases the Susceptibility to HIV-1 Acquisition
3. The Increase in HPV Infection is an Early Event after HIV-1 Infection
4. HIV-1 Infection Increases Prevalence, Persistence and Reduces Clearance of HPV
5. HPV, HIV-1 and Cervical Cancer
6. Circumcision Reduces HIV-1 and HPV Acquisition
7. Impact of Microbicides on HIV-1 and HPV
8. Condoms, HIV-1 and HPV
9. HPV Vaccines in HIV-1 Positive Women
10. Conclusions
Acknowledgments
Conflicts of Interest
References
- Chen, C.J.; Hsu, W.L.; Yang, H.I.; Lee, M.H.; Chen, H.C.; Chien, Y.C.; You, S.L. Epidemiology of virus infection and human cancer. Recent Results Cancer Res. 2014, 193, 11–32. [Google Scholar] [PubMed]
- Zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991, 184, 9–13. [Google Scholar]
- Denny, L. Cervical cancer: Prevention and treatment. Discov. Med. 2012, 14, 125–131. [Google Scholar] [PubMed]
- De Vuyst, H.; Alemany, L.; Lacey, C.; Chibwesha, C.J.; Sahasrabuddhe, V.; Banura, C.; Denny, L.; Parham, G.P. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine 2013, 31 (Suppl. S5), F32–F46. [Google Scholar] [CrossRef] [PubMed]
- Zur Hausen, H. Papillomaviruses in the causation of human cancers—A brief historical account. Virology 2009, 384, 260–265. [Google Scholar]
- Mwololo, A.; Nyagol, J.; Rogena, E.; Ochuk, W.; Kimani, M.; Onyango, N.; Pacenti, L.; Santopietro, R.; Leoncini, L.; Mwanda, W. Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva. Infect. Agents Cancer 2014, 9. [Google Scholar] [CrossRef]
- Pantanowitz, L.; Michelow, P. Review of human immunodeficiency virus (HIV) and squamous lesions of the uterine cervix. Diagn. Cytopathol. 2011, 39, 65–72. [Google Scholar] [CrossRef] [PubMed]
- Auvert, B.; Marais, D.; Lissouba, P.; Zarca, K.; Ramjee, G.; Williamson, A.L. High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infect. Dis. Obstet. Gynecol. 2011, 2011. [Google Scholar] [CrossRef]
- Houlihan, C.F.; Larke, N.L.; Watson-Jones, D.; Smith-McCune, K.K.; Shiboski, S.; Gravitt, P.E.; Smith, J.S.; Kuhn, L.; Wang, C.; Hayes, R. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. Aids 2012, 26, 2211–2222. [Google Scholar] [CrossRef] [PubMed]
- Mbulawa, Z.Z.; Marais, D.J.; Johnson, L.F.; Boulle, A.; Coetzee, D.; Williamson, A.L. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J. Gen. Virol. 2010, 91, 3023–3031. [Google Scholar] [CrossRef] [PubMed]
- Lissouba, P.; Van de Perre, P.; Auvert, B. Association of genital human papillomavirus infection with HIV acquisition: A systematic review and meta-analysis. Sex. Transm. Infect. 2013, 89, 350–356. [Google Scholar] [CrossRef] [PubMed]
- Averbach, S.H.; Gravitt, P.E.; Nowak, R.G.; Celentano, D.D.; Dunbar, M.S.; Morrison, C.S.; Grimes, B.; Padian, N.S. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. Aids 2010, 24, 1035–1042. [Google Scholar] [CrossRef] [PubMed]
- Tobian, A.A.; Grabowski, M.K.; Kigozi, G.; Redd, A.D.; Eaton, K.P.; Serwadda, D.; Cornish, T.C.; Nalugoda, F.; Watya, S.; Buwembo, D.; et al. Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin. J. Infect. Dis. 2013, 207, 1713–1722. [Google Scholar] [CrossRef] [PubMed]
- Tong, W.W.; Shepherd, K.; Garland, S.; Meagher, A.; Templeton, D.J.; Fairley, C.K.; Jin, F.; Poynten, I.M.; Zaunders, J.; Hillman, R.J.; et al. Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions. J. Infect. Dis. 2015, 211, 405–415. [Google Scholar] [CrossRef] [PubMed]
- Coleman, N.; Birley, H.D.; Renton, A.M.; Hanna, N.F.; Ryait, B.K.; Byrne, M.; Taylor-Robinson, D.; Stanley, M.A. Immunological events in regressing genital warts. Am. J. Clin. Pathol. 1994, 102, 768–774. [Google Scholar] [PubMed]
- Kim, K.H.; Greenfield, W.W.; Cannon, M.J.; Coleman, H.N.; Spencer, H.J.; Nakagawa, M. CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend. Cancer Immunol. Immunother. CII 2012, 61, 63–70. [Google Scholar] [CrossRef]
- Ameur, A.; Meiring, T.L.; Bunikis, I.; Haggqvist, S.; Lindau, C.; Lindberg, J.H.; Gustavsson, I.; Mbulawa, Z.Z.; Williamson, A.L.; Gyllensten, U. Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing. Sci. Rep. 2014, 4. [Google Scholar] [CrossRef] [PubMed]
- Van de Velde, N.; Boily, M.C.; Drolet, M.; Franco, E.L.; Mayrand, M.H.; Kliewer, E.V.; Coutlee, F.; Laprise, J.F.; Malagon, T.; Brisson, M. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: A model-based analysis. J. Natl. Cancer Inst. 2012, 104, 1712–1723. [Google Scholar] [CrossRef] [PubMed]
- Joura, E.A.; Giuliano, A.R.; Iversen, O.E.; Bouchard, C.; Mao, C.; Mehlsen, J.; Moreira, E.D., Jr.; Ngan, Y.; Petersen, L.K.; Lazcano-Ponce, E.; et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N. Engl. J. Med. 2015, 372, 711–723. [Google Scholar] [CrossRef] [PubMed]
- Firnhaber, C.; Zungu, K.; Levin, S.; Michelow, P.; Montaner, L.J.; McPhail, P.; Williamson, A.L.; Allan, B.R.; Van der Horst, C.; Rinas, A.; et al. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol. 2009, 53, 10–17. [Google Scholar] [CrossRef] [PubMed]
- Marais, D.J.; Carrara, H.; Ramjee, G.; Kay, P.; Williamson, A.L. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers. J. Med. Virol. 2009, 81, 203–210. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Wright, T.C.; Denny, L.; Kuhn, L. Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J. Infect. Dis. 2011, 203, 479–486. [Google Scholar] [CrossRef] [PubMed]
- Nowak, R.G.; Gravitt, P.E.; Morrison, C.S.; Gange, S.J.; Kwok, C.; Oliver, A.E.; Howard, R.; Van der Pol, B.; Salata, R.A.; Padian, N.S.; et al. Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J. Infect. Dis. 2011, 203, 1182–1191. [Google Scholar] [CrossRef] [PubMed]
- Chirgwin, K.D.; Feldman, J.; Augenbraun, M.; Landesman, S.; Minkoff, H. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J. Infect. Dis. 1995, 172, 235–238. [Google Scholar] [CrossRef] [PubMed]
- Maglennon, G.A.; McIntosh, P.B.; Doorbar, J. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J. Virol. 2014, 88, 710–716. [Google Scholar] [CrossRef] [PubMed]
- Doorbar, J. Latent papillomavirus infections and their regulation. Curr. Opin. Virol. 2013, 3, 416–421. [Google Scholar] [CrossRef] [PubMed]
- McDonald, A.C.; Tergas, A.I.; Kuhn, L.; Denny, L.; Wright, T.C., Jr. Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa. Front. Oncol. 2014, 4. [Google Scholar] [CrossRef]
- Moodley, J.R.; Constant, D.; Hoffman, M.; Salimo, A.; Allan, B.; Rybicki, E.; Hitzeroth, I.; Williamson, A.L. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: A cross-sectional study. BMC Cancer 2009, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Firnhaber, C.; Mayisela, N.; Mao, L.; Williams, S.; Swarts, A.; Faesen, M.; Levin, S.; Michelow, P.; Omar, T.; Hudgens, M.G.; et al. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS ONE 2013, 8, e53494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olesen, T.B.; Munk, C.; Christensen, J.; Andersen, K.K.; Kjaer, S.K. Human papillomavirus prevalence among men in sub-Saharan Africa: A systematic review and meta-analysis. Sex. Transm. Infect. 2014, 90, 455–462. [Google Scholar] [CrossRef] [PubMed]
- De Sanjose, S.; Diaz, M.; Castellsague, X.; Clifford, G.; Bruni, L.; Munoz, N.; Bosch, F.X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect. Dis. 2007, 7, 453–459. [Google Scholar] [CrossRef] [PubMed]
- Mbulawa, Z.Z.; Marais, D.J.; Johnson, L.F.; Coetzee, D.; Williamson, A.L. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J. Infect. Dis. 2012, 206, 15–27. [Google Scholar] [CrossRef] [PubMed]
- Rositch, A.F.; Koshiol, J.; Hudgens, M.G.; Razzaghi, H.; Backes, D.M.; Pimenta, J.M.; Franco, E.L.; Poole, C.; Smith, J.S. Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis. Int. J. Cancer J. Int. Cancer 2013, 133, 1271–1285. [Google Scholar] [CrossRef]
- Guan, P.; Howell-Jones, R.; Li, N.; Bruni, L.; de Sanjose, S.; Franceschi, S.; Clifford, G.M. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int. J. Cancer J. Int. Cancer 2012, 131, 2349–2359. [Google Scholar] [CrossRef]
- Denny, L.; Adewole, I.; Anorlu, R.; Dreyer, G.; Moodley, M.; Smith, T.; Snyman, L.; Wiredu, E.; Molijn, A.; Quint, W.; et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int. J. Cancer J. Int. Cancer 2014, 134, 1389–1398. [Google Scholar] [CrossRef]
- Carrillo-Garcia, A.; Ponce-de-Leon-Rosales, S.; Cantu-de-Leon, D.; Fragoso-Ontiveros, V.; Martinez-Ramirez, I.; Orozco-Colin, A.; Mohar, A.; Lizano, M. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. Gynecol. Oncol. 2014, 134, 534–539. [Google Scholar] [CrossRef] [PubMed]
- Wang, S.M.; Colombara, D.; Shi, J.F.; Zhao, F.H.; Li, J.; Chen, F.; Chen, W.; Li, S.M.; Zhang, X.; Pan, Q.J.; et al. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses. Int. J. Gynecol. Cancer 2013, 23, 716–723. [Google Scholar] [CrossRef] [PubMed]
- Depuydt, C.E.; Criel, A.M.; Benoy, I.H.; Arbyn, M.; Vereecken, A.J.; Bogers, J.J. Changes in type-specific human papillomavirus load predict progression to cervical cancer. J. Cell. Mol. Med. 2012, 16, 3096–3104. [Google Scholar] [CrossRef] [PubMed]
- Mbulawa, Z.Z.; Johnson, L.F.; Marais, D.J.; Gustavsson, I.; Moodley, J.R.; Coetzee, D.; Gyllensten, U.; Williamson, A.L. Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women. BMC Infect. Dis. 2014, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moodley, M.; Moodley, J.; Kleinschmidt, I. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: A South African perspective. Int. J. Gynecol. Cancer 2001, 11, 194–197. [Google Scholar] [CrossRef] [PubMed]
- Moodley, J.R.; Hoffman, M.; Carrara, H.; Allan, B.R.; Cooper, D.D.; Rosenberg, L.; Denny, L.E.; Shapiro, S.; Williamson, A.L. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: A case-control study. BMC Cancer 2006, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cobucci, R.N.; Lima, P.H.; de Souza, P.C.; Costa, V.V.; Cornetta, M.D.; Fernandes, J.V.; Goncalves, A.K. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. J. Infect. Public Health 2014, 8, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Russomano, F.; Paz, B.R.; Camargo, M.J.; Grinstejn, B.G.; Friedman, R.K.; Tristao, M.A.; Oliveira, C.A. Recurrence of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women treated by means of electrosurgical excision of the transformation zone (LLETZ) in Rio de Janeiro, Brazil. Sao Paulo Med. J. 2013, 131, 405–410. [Google Scholar] [PubMed]
- Mungo, C.; Cohen, C.R.; Maloba, M.; Bukusi, E.A.; Huchko, M.J. Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya. Int. J. Gynaecol. Obstet. 2013, 123, 231–235. [Google Scholar] [CrossRef] [PubMed]
- Foulot, H.; Heard, I.; Potard, V.; Costagliola, D.; Chapron, C. Surgical management of cervical intraepithelial neoplasia in HIV-infected women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 141, 153–157. [Google Scholar] [CrossRef] [PubMed]
- Zeier, M.D.; Botha, M.H.; Engelbrecht, S.; Machekano, R.N.; Jacobs, G.B.; Isaacs, S.; van Schalkwyk, M.; van der Merwe, H.; Mason, D.; Nachega, J.B. Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV. Aids 2015, 29, 59–66. [Google Scholar] [CrossRef] [PubMed]
- Shrestha, S.; Sudenga, S.L.; Smith, J.S.; Bachmann, L.H.; Wilson, C.M.; Kempf, M.C. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect. Dis. 2010, 10. [Google Scholar] [CrossRef]
- Kuhn, L.; Wang, C.; Tsai, W.Y.; Wright, T.C.; Denny, L. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. Aids 2010, 24, 2553–2561. [Google Scholar] [CrossRef] [PubMed]
- Denny, L.A.; Franceschi, S.; de Sanjose, S.; Heard, I.; Moscicki, A.B.; Palefsky, J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012, 30 (Suppl. S5), F168–F174. [Google Scholar] [CrossRef] [PubMed]
- Cambou, M.C.; Luz, P.M.; Lake, J.E.; Levi, J.E.; Coutinho, J.R.; de Andrade, A.; Heinke, T.; Derrico, M.; Veloso, V.G.; Friedman, R.K.; et al. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDs 2015, 29, 4–12. [Google Scholar] [CrossRef] [PubMed]
- Heard, I.; Etienney, I.; Potard, V.; Poizot-Martin, I.; Moore, C.; Lesage, A.C.; Ressiot, E.; Crenn-Hebert, C.; Flejou, J.F.; Cubie, H.; et al. High prevalence of anal human papillomavirus-associated cancer precursors in a contemporary cohort of asymptomatic HIV-infected women. Clin. Infect. Dis. 2015. [Google Scholar] [CrossRef]
- Alemany, L.; Saunier, M.; Alvarado-Cabrero, I.; Quiros, B.; Salmeron, J.; Shin, H.R.; Pirog, E.C.; Guimera, N.; Hernandez-Suarez, G.; Felix, A.; et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int. J. Cancer 2015, 136, 98–107. [Google Scholar] [CrossRef] [PubMed]
- Ravenda, P.S.; Magni, E.; Botteri, E.; Manzotti, M.; Barberis, M.; Vacirca, D.; Trovato, C.M.; Dell’Acqua, V.; Leonardi, M.C.; Sideri, M.; et al. Prognostic value of human papillomavirus in anal squamous cell carcinoma. Cancer Chemother. Pharmacol. 2014, 74, 1033–1038. [Google Scholar] [CrossRef] [PubMed]
- Auvert, B.; Taljaard, D.; Rech, D.; Lissouba, P.; Singh, B.; Bouscaillou, J.; Peytavin, G.; Mahiane, S.G.; Sitta, R.; Puren, A.; et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: Evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013, 10, e1001509. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention (CDC). Voluntary medical male circumcision—Southern and eastern Africa, 2010–2012. MMWR Morb. Mortal. Wkly. Rep. 2013, 62, 953–957. [Google Scholar]
- Siegfried, N.; Muller, M.; Deeks, J.J.; Volmink, J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst. Rev. 2009. [Google Scholar] [CrossRef]
- Senkomago, V.; Backes, D.M.; Hudgens, M.G.; Poole, C.; Agot, K.; Moses, S.; Snijders, P.J.; Meijer, C.J.; Hesselink, A.T.; Schlecht, N.F.; et al. Acquisition and persistence of high viral load HPV16 and HPV18 infections in men enrolled in a circumcision trial in Kisumu, Kenya. J. Infect. Dis. 2015, 211, 811–820. [Google Scholar] [CrossRef] [PubMed]
- Davis, M.A.; Gray, R.H.; Grabowski, M.K.; Serwadda, D.; Kigozi, G.; Gravitt, P.E.; Nalugoda, F.; Watya, S.; Wawer, M.J.; Quinn, T.C.; et al. Male circumcision decreases high-risk human papillomavirus viral load in female partners: A randomized trial in Rakai, Uganda. Int. J. Cancer 2013, 133, 1247–1252. [Google Scholar] [CrossRef] [PubMed]
- Rositch, A.F.; Mao, L.; Hudgens, M.G.; Moses, S.; Agot, K.; Backes, D.M.; Nyagaya, E.; Snijders, P.J.; Meijer, C.J.; Bailey, R.C.; et al. Risk of HIV acquisition among circumcised and uncircumcised young men with penile human papillomavirus infection. Aids 2014, 28, 745–752. [Google Scholar] [CrossRef] [PubMed]
- Abdool Karim, Q.; Abdool Karim, S.S.; Frohlich, J.A.; Grobler, A.C.; Baxter, C.; Mansoor, L.E.; Kharsany, A.B.; Sibeko, S.; Mlisana, K.P.; Omar, Z.; et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329, 1168–1174. [Google Scholar] [CrossRef] [PubMed]
- Van Damme, L.; Ramjee, G.; Alary, M.; Vuylsteke, B.; Chandeying, V.; Rees, H.; Sirivongrangson, P.; Mukenge-Tshibaka, L.; Ettiegne-Traore, V.; Uaheowitchai, C.; et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 2002, 360, 971–977. [Google Scholar] [CrossRef] [PubMed]
- Marais, D.; Carrara, H.; Kay, P.; Ramjee, G.; Allan, B.; Williamson, A.L. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. Virus Res. 2006, 121, 220–222. [Google Scholar] [CrossRef] [PubMed]
- Ramjee, G.; Kamali, A.; McCormack, S. The last decade of microbicide clinical trials in Africa: From hypothesis to facts. Aids 2010, 24 (Suppl. S4), S40–S49. [Google Scholar] [CrossRef] [PubMed]
- Marais, D.; Gawarecki, D.; Allan, B.; Ahmed, K.; Altini, L.; Cassim, N.; Gopolang, F.; Hoffman, M.; Ramjee, G.; Williamson, A.L. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir. Ther. 2011, 16, 1219–1226. [Google Scholar] [CrossRef] [PubMed]
- Roberts, J.N.; Buck, C.B.; Thompson, C.D.; Kines, R.; Bernardo, M.; Choyke, P.L.; Lowy, D.R.; Schiller, J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13, 857–861. [Google Scholar] [CrossRef] [PubMed]
- Kizima, L.; Rodriguez, A.; Kenney, J.; Derby, N.; Mizenina, O.; Menon, R.; Seidor, S.; Zhang, S.; Levendosky, K.; Jean-Pierre, N.; et al. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS ONE 2014, 9, e94547. [Google Scholar] [CrossRef] [PubMed]
- Pierce Campbell, C.M.; Lin, H.Y.; Fulp, W.; Papenfuss, M.R.; Salmeron, J.J.; Quiterio, M.M.; Lazcano-Ponce, E.; Villa, L.L.; Giuliano, A.R. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: The HPV infection in men study. J. Infect. Dis. 2013, 208, 373–384. [Google Scholar] [CrossRef] [PubMed]
- Davis, K.R.; Weller, S.C. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam. Plan. Perspect. 1999, 31, 272–279. [Google Scholar] [CrossRef]
- Giacomet, V.; Penagini, F.; Trabattoni, D.; Vigano, A.; Rainone, V.; Bernazzani, G.; Bonardi, C.M.; Clerici, M.; Bedogni, G.; Zuccotti, G.V. Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults. Vaccine 2014, 32, 5657–5661. [Google Scholar] [CrossRef] [PubMed]
- Kojic, E.M.; Kang, M.; Cespedes, M.S.; Umbleja, T.; Godfrey, C.; Allen, R.T.; Firnhaber, C.; Grinsztejn, B.; Palefsky, J.M.; Webster-Cyriaque, J.Y.; et al. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin. Infect. Dis. 2014, 59, 127–135. [Google Scholar] [CrossRef] [PubMed]
- Denny, L.; Hendricks, B.; Gordon, C.; Thomas, F.; Hezareh, M.; Dobbelaere, K.; Durand, C.; Herve, C.; Descamps, D. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study. Vaccine 2013, 31, 5745–5753. [Google Scholar] [CrossRef] [PubMed]
- Burger, E.A.; Sy, S.; Nygard, M.; Kristiansen, I.S.; Kim, J.J. Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway. J. Infect. Dis. 2015, 211, 206–215. [Google Scholar] [CrossRef] [PubMed]
- Chow, E.P.; Read, T.R.; Wigan, R.; Donovan, B.; Chen, M.Y.; Bradshaw, C.S.; Fairley, C.K. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex. Transm. Infect. 2014. [Google Scholar] [CrossRef]
- Pollock, K.G.; Kavanagh, K.; Potts, A.; Love, J.; Cuschieri, K.; Cubie, H.; Robertson, C.; Cruickshank, M.; Palmer, T.J.; Nicoll, S.; et al. Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland. Br. J. Cancer 2014, 111, 1824–1830. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.J.; Campos, N.G.; O’Shea, M.; Diaz, M.; Mutyaba, I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine 2013, 31 (Suppl. S5), F60–F72. [Google Scholar] [CrossRef] [PubMed]
- Mutevedzi, P.C.; Newell, M.L. The changing face of the HIV epidemic in sub-Saharan Africa. Trop. Med. Int. Health TM IH 2014, 19, 1015–1028. [Google Scholar] [CrossRef]
- Denslow, S.A.; Rositch, A.F.; Firnhaber, C.; Ting, J.; Smith, J.S. Incidence and progression of cervical lesions in women with HIV: A systematic global review. Int. J. STD AIDS 2014, 25, 163–177. [Google Scholar] [CrossRef] [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Williamson, A.-L. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. J. Clin. Med. 2015, 4, 579-592. https://doi.org/10.3390/jcm4040579
Williamson A-L. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. Journal of Clinical Medicine. 2015; 4(4):579-592. https://doi.org/10.3390/jcm4040579
Chicago/Turabian StyleWilliamson, Anna-Lise. 2015. "The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa" Journal of Clinical Medicine 4, no. 4: 579-592. https://doi.org/10.3390/jcm4040579